Baraliakos X, et al. Long-Term Evaluation of Secukinumab in Ankylosing Spondylitis: 5 Year Efficacy and Safety Results from a Phase 3 Trial. ACR 2018, abstract L13.
EULAR-standpunt over gebruik van (hydroxy)chloroquine voor COVID-19
apr 2020 | RA, Virale infecties